Synthesis of folic acid-conjugated glycodendrimer with magnetic β-cyclodextrin core as a pH-responsive system for tumor-targeted co-delivery of doxorubicin and curcumin

Synthesis of folic acid-conjugated glycodendrimer with magnetic β-cyclodextrin core as a pH-responsive system for tumor-targeted co-delivery of doxorubicin and curcumin


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: دکتر حسن نمازی

کلمات کلیدی: Targeted delivery, β-cyclodextrin, Magnetic glycodendrimer, Nanocomposite, Cytotoxicity

نشریه: 7621 , 2021 , 627 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله دکتر حسن نمازی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ریز فناوری دارویی
کد مقاله 78428
عنوان فارسی مقاله Synthesis of folic acid-conjugated glycodendrimer with magnetic β-cyclodextrin core as a pH-responsive system for tumor-targeted co-delivery of doxorubicin and curcumin
عنوان لاتین مقاله Synthesis of folic acid-conjugated glycodendrimer with magnetic β-cyclodextrin core as a pH-responsive system for tumor-targeted co-delivery of doxorubicin and curcumin
ناشر 2
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

One of the most important applications of nanotechnology in cancer treatment involves the design of magnetic nanocomposites for the targeted delivery of anticancer drugs to cancer cells. This study aims to develop a novel, appropriate, and efficient magnetic carrier having antioxidant properties for the controlled release of anticancer drugs, hydrophilic doxorubicin (DOX), and hydrophobic curcumin (CUR) to cancer cells using folic acid conjugated with magnetic glycodendrimer (Fe3O4-β-CD-CTD-FA). The synthesized carrier was characterized using DLS, EDX, XRD, BET, FT‐IR, Zeta potential, VSM, TEM, and SEM analysis. The TEM results showed that synthesized Fe3O4-β-CD-CTD-FA have a spherical-like core-shell structure with an average diameter of approximately 533 nm. The encapsulation efficiency (EE) of Fe3O4-β-CD-CTD-FA was found to be 98.96% for DOX and 70.91% for CUR. The release studies of DOX and CUR from Fe3O4-β-CD-CTD-FA showed that maximum release occurs at pH 5 which means it has a controlled pH-responsive behavior. In vitro cytotoxicity and confocal microscopy of the as-synthesized Fe3O4-β-CD-CTD-FA in MDA-MB-231 cells clearly showed that the prepared carrier had no significant cytotoxicity and could easily enter the cell. Furthermore, the in vitro antioxidant capacity of Fe3O4-β-CD-CTD-FA was evaluated by DPPH assay and the results exhibited that the synthesized carrier has excellent antioxidant activity (75.45%). Therefore, the obtained glycodendrimer in this study due to their target ability under a magnetic field, excellent biocompatibility, good colloidal stability, simple preparing method, and good antioxidant activity could be used as a promising targeted co-drug delivery system for cancer therapy.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
دکتر حسن نمازیدوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
7 P 2021 Karimi (Colloids and Surfaces A ).pdf1401/01/167977075دانلود